A

Athera Biotechnologies AB

10 employees

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cardiovascular disease
Clinical stage development
Immunovascular disease
oxidised phospolipids
vascular inflammation
Pharmaceutical
Therapeutic antibodies
Fully human monoclonal antibodies

Date founded

2005

Funding rounds raised

Total raised

$7.2M

from 5 investors over 5 rounds

A

Athera Biotechnologies AB raised $5.9M on April 21, 2019

Investors: Industrifonden and Sciety

A

Athera Biotechnologies AB raised $7.2M on August 29, 2017

Investors: Industrifonden

A

Athera Biotechnologies AB raised $2.8M on December 13, 2015

Investors: Industrifonden

A

Athera Biotechnologies AB raised undisclosed on December 20, 2013

Investors: Texas Venture Labs

FAQ